HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

aureusidin

structure in first source

Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzofurans: 26
      - aureusidin: 4

Experts

1.	Guan, Qiaobing: 1 article (01/2021)
2.	Li, Wenyan: 1 article (01/2021)
3.	Ruan, Shuiliang: 1 article (01/2021)
4.	Shen, Heping: 1 article (01/2021)
5.	Sheng, Yongjia: 1 article (01/2021)
6.	Wang, Jin: 1 article (01/2021)
7.	Yang, Yi: 1 article (01/2021)
8.	Zhou, Xiaohong: 1 article (01/2021)
9.	Cai, Heng: 1 article (01/2020)
10.	Hu, Kun: 1 article (01/2020)

Related Diseases

1.	Neurodegenerative Diseases (Neurodegenerative Disease) 09/15/2013 - "Evaluation by in vitro assay and docking simulations for CDK5/p25 revealed that the aurones, sulfuretin (1) and aureusidin (2), the aurone glycoside, aureusidin-6-O-β-D-glucopyranoside (3) and hovetrichoside C (4), the flavonoid glycoside, quercetin-3-O-β-D-galactopyranoside (5), and the biflavonoid, cupressuflavone (6), had the potential to inhibit CDK5/p25, which could be useful in the treatment of neurodegenerative disorders such as Alzheimer's disease. "
2.	Alzheimer Disease (Alzheimer's Disease) 09/15/2013 - "Evaluation by in vitro assay and docking simulations for CDK5/p25 revealed that the aurones, sulfuretin (1) and aureusidin (2), the aurone glycoside, aureusidin-6-O-β-D-glucopyranoside (3) and hovetrichoside C (4), the flavonoid glycoside, quercetin-3-O-β-D-galactopyranoside (5), and the biflavonoid, cupressuflavone (6), had the potential to inhibit CDK5/p25, which could be useful in the treatment of neurodegenerative disorders such as Alzheimer's disease. "
3.	Inflammation (Inflammations) 01/01/2020 - "Based on the above results, Aureusidin may be an attractive therapeutic candidate for the inflammation-related diseases." 01/01/2021 - "Our previous study has found that aureusidin can inhibit inflammation by targeting myeloid differentiation 2 (MD2) protein. " 01/01/2021 - "Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein."
4.	Osteoporosis 07/01/2021 - "Notably, gentisin and aureusidin among the identified compounds were first predicted to be associated with osteoporosis. "
5.	Colitis 01/01/2021 - "Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein."

Related Drugs and Biologics

1.	Biflavonoids
2.	Glycosides
3.	Flavonoids
4.	aurone
5.	sulfuretin
6.	cupressuflavone
7.	Proteins (Proteins, Gene)
8.	6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)
9.	gentisin